共 50 条
- [31] REMISSION INDUCTION IN ACUTE NONLYMPHOCYTIC LEUKEMIA - COMPARISON OF A 7-DAY AND 10-DAY INFUSION OF CYTOSINE-ARABINOSIDE IN COMBINATION WITH ADRIAMYCIN MEDICAL AND PEDIATRIC ONCOLOGY, 1979, 7 (03): : 269 - 275
- [32] MAINTENANCE OF REMISSION IN ADULT ACUTE NONLYMPHOBLASTIC LEUKEMIA USING INTERMITTENT COURSES OF CYTOSINE-ARABINOSIDE (NSC-63878) AND 6-THIOGUANINE (NSC-752) CANCER TREATMENT REPORTS, 1976, 60 (05): : 585 - 589
- [33] L-ASPARAGINASE AND PREDNISOLONE PRETREATMENT FOLLOWED BY RUBIDOMYCIN AND CYTOSINE-ARABINOSIDE FOR INDUCTION OF REMISSION IN ADULT PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1975, 15 (01): : 72 - 80
- [34] REMISSION INDUCTION IN CHILDREN WITH ACUTE NON-LYMPHOCYTIC LEUKEMIA USING CYTOSINE-ARABINOSIDE AND DOXORUBICIN OR DAUNORUBICIN - A REPORT FROM THE CHILDRENS CANCER STUDY-GROUP MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (05): : 382 - 390
- [38] RELATIONSHIP BETWEEN LEUKEMIC-CELL RETENTION OF CYTOSINE-ARABINOSIDE TRIPHOSPHATE AND THE DURATION OF REMISSION IN PATIENTS WITH ACUTE NON-LYMPHOCYTIC LEUKEMIA EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (01): : 23 - 30
- [39] DAUNORUBICIN (NSC-82151), VINCRISTINE (NSC-67574), CYTOSINE-ARABINOSIDE (NSC-63878), AND PREDNISONE (NSC-10023) COMBINATION THERAPY FOR ADVANCED ADULT ACUTE-LEUKEMIA CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (04): : 757 - 760
- [40] INTENSIFIED INDUCTION THERAPY WITH BEHENOYL CYTOSINE-ARABINOSIDE, DAUNORUBICIN, 6-MERCAPTOPURINE AND PREDNISOLONE (BHAC-DMP (II)) THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN ADULTS AND PROGNOSTIC FACTORS RELATED TO REMISSION DURATION ACTA HAEMATOLOGICA JAPONICA, 1990, 53 (04): : 707 - 716